Viral vaccine composition, process and methods of use
AssigneeImmunitor USA Inc.
InventorsVichai Jirathitikal, Aldar Bourinbaiar
Life of this patent
Estimating the term…
Abstract
A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition's use. The composition comprises viral pathogen-infected cell or tissue, or malignantly or immunologically aberrant cells or tissues which has been reduced and/or denatured. The preferred composition is administered across a mucosal surface of an animal suffering or about suffer from infection. The composition is administered as preventive or therapeutic vaccine.
Claims10
A composition comprising denatured hepatitis type B or type C viral pathogen, wherein the pathogens are denatured through a method comprising drying the pathogen and denaturing the resulting dried pathogen using heat alone, wherein the composition is formulated as an oral pill.
A hepatitis immunogen comprising heat denatured hepatitis virus type B and type C, wherein the hepatitis B virus and hepatitis C virus are denatured through a method comprising drying the hepatitis B virus and hepatitis C virus and denaturing the resulting dried viruses using heat alone to produce the immunogen, wherein the immunogen is formulated as an oral pill.
An oral composition suitable for inducing an immune response in a subject, the composition comprising a first component comprising denatured hepatitis type B or type C viral pathogen, wherein the pathogens are denatured through a method comprising drying the pathogen and denaturing the resulting dried pathogen using heat alone, and a second component comprising a denatured pooled blood tissue from a host infected by hepatitis virus type B and type C.
Dependencies are inferred from the claim text.